WT1 PEPTIDE-BASED CANCER IMMUNOTHERAPY

被引：0
|
作者：
Sugiyama, H. [1 ]
机构：
[1] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka 565, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [41] WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
    Miyatake, Takashi
    Ueda, Yutaka
    Morimoto, Akiko
    Enomoto, Takayuki
    Nishida, Sumiyuki
    Shirakata, Toshiaki
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Oji, Yusuke
    Hosen, Naoki
    Nakatsuka, Shin-ichi
    Morita, Satoshi
    Sakamoto, Junichi
    Sugiyama, Haruo
    Kimura, Tadashi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (03) : 457 - 463
  • [42] WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
    Takashi Miyatake
    Yutaka Ueda
    Akiko Morimoto
    Takayuki Enomoto
    Sumiyuki Nishida
    Toshiaki Shirakata
    Yoshihiro Oka
    Akihiro Tsuboi
    Yusuke Oji
    Naoki Hosen
    Shin-ichi Nakatsuka
    Satoshi Morita
    Junichi Sakamoto
    Haruo Sugiyama
    Tadashi Kimura
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 457 - 463
  • [43] TUMOR IMMUNOTHERAPY TARGETING WT1 (WILMS' TUMOR GENE) PEPTIDE FOR PEDIATRIC RARE TUMORS
    Hashii, Y.
    Oka, Y.
    Ozono, K.
    Sugiyama, H.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 155 - 155
  • [44] WT1 peptide vaccines in leukaemias and WT-1 expressing carcinomas
    Keilholz, U.
    EJC SUPPLEMENTS, 2007, 5 (04): : 29 - 29
  • [45] Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
    Ichinohasama, Ryo
    Oji, Yusuke
    Yokoyama, Hisayuki
    Takeuchi, Kengo
    Fujiwara, Tohru
    Ishizawa, Kenichi
    Taniguchi, Osamu
    Tsuboi, Akihiro
    Oka, Yoshihiro
    Sugiyama, Haruo
    CANCER SCIENCE, 2010, 101 (05) : 1089 - 1092
  • [46] WT1 peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers
    Oka, Yoshihiro
    Tsuboi, Akihiro
    Elisseeva, Olga A.
    Nakajima, Hiroko
    Fujiki, Fumihiro
    Kawakami, Manabu
    Shirakata, Toshiaki
    Nishida, Sumiyuki
    Hosen, Naoki
    Oji, Yusuke
    Kawase, Ichiro
    Sugiyama, Haruo
    THESCIENTIFICWORLDJOURNAL, 2007, 7 : 649 - 665
  • [47] Pro-inflammatory responses after peptide-based cancer immunotherapy
    Mahaki, Hanie
    Ravari, Hassan
    Kazemzadeh, Gholamhossein
    Lotfian, Elham
    Daddost, Rahele Amir
    Avan, Amir
    Manoochehri, Hamed
    Sheykhhasan, Mohsen
    Mahmoudian, Reihaneh Alsadat
    Tanzadehpanah, Hamid
    HELIYON, 2024, 10 (11)
  • [48] Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy
    Liu, Yating
    Yao, Lintong
    Cao, Wenpeng
    Liu, Yajing
    Zhai, Wenjie
    Wu, Yahong
    Wang, Binglin
    Gou, Shanshan
    Qin, Yaping
    Qi, Yuanming
    Chen, Zhenzhen
    Gao, Yanfeng
    ACS APPLIED BIO MATERIALS, 2019, 2 (03) : 1241 - 1254
  • [49] Determinant spreading and tumor responses after peptide-based cancer immunotherapy
    Ribas, A
    Timmerman, JM
    Butterfield, LH
    Economou, JS
    TRENDS IN IMMUNOLOGY, 2003, 24 (02) : 58 - 61
  • [50] Enhanced Depot Vaccine Formulations for Targeted Peptide-based Cancer Immunotherapy
    Karkada, Mahan
    Sinnathamby, G.
    Weir, Genevieve
    Sammatur, Leelahdar
    Philip, Ramila
    Mansour, Marc
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 942 - 942
12345